Eden Research plc (LON:EDEN – Get Free Report)’s share price rose 2.8% during trading on Wednesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares were traded during mid-day trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,852.46).
Eden Research Trading Down 2.7 %
The stock has a market cap of £21.01 million, a PE ratio of -200.00 and a beta of 0.92. The company’s fifty day moving average is GBX 3.89 and its 200-day moving average is GBX 4. The company has a debt-to-equity ratio of 1.25, a current ratio of 3.80 and a quick ratio of 2.42.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
See Also
- Five stocks we like better than Eden Research
- What to Know About Investing in Penny Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to invest in marijuana stocks in 7 steps
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.